Barbara Cocuroccia
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Real-Life Effectiveness, Safety, and Growth Outcomes of Dupilumab in Children Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis: A Multicenter Retrospective Study from an Italian NPP Program.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: May 07, 2026
Genetic profiling of patients with atopic dermatitis reveals immune and skin barrier variants associated with generalized eczema and optimal response to Dupilumab therapy.
Journal: Frontiers in immunology
Published: January 15, 2026
Unmasking the High Prevalence of Psychological Morbidity in Atopic Dermatitis-A Call for Routine Screening.
Journal: International journal of dermatology
Published: October 20, 2025
Syphilis, the great mimicker: an inverted diagnostic pathway that still hits the mark.
Journal: Dermatology reports
Published: August 21, 2025
Successful use of dupilumab in a patient with atopic dermatitis and autosomal dominant polycystic kidney disease: a case report.
Journal: Dermatology reports
Published: July 10, 2025
Erythrodermic atopic dermatitis successfully treated with upadacitinib.
Journal: Italian journal of dermatology and venereology
Published: July 02, 2025
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?
Journal: The Journal of dermatological treatment
Published: June 09, 2025
Biological therapies in infants and children younger than 6 years of age with atopic dermatitis: suitability and practical considerations.
Journal: Expert opinion on drug safety
Published: December 21, 2024
Juvenile gangrenous vasculitis of the scrotum: a rare entity and a diagnostic challenge.
Journal: Italian journal of dermatology and venereology
Published: December 17, 2024
Evaluation of Upadacitinib Efficacy in the Treatment of Atopic Dermatitis of Sensitive Areas.
Journal: Dermatology (Basel, Switzerland)
Published: November 22, 2024
Effectiveness and Safety of Upadacitinib for Adolescents with Atopic Dermatitis in a Real-World Setting.
Journal: Clinical drug investigation
Published: July 07, 2024
A microarray-based IgE-molecular mimicry index (IgE-MMI): A biomarker for disease severity, clinical phenotypes, and therapeutic response in atopic dermatitis?
Journal: Allergy
Published: June 18, 2024
Last Updated: 09/26/2026